Crystal Pharmatech Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
180
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$92.8M
- Investors
-
7
Crystal Pharmatech General Information
Description
Developer and provider of solid-state chemistry services intended to focus on material science and engineering for drug development. The company's services include a range of services from screening and evaluation to processing for active pharmaceutical ingredients and formulations, serving the pharmaceutical industry to develop new drugs efficiently.
Contact Information
Website
www.crystalpharmatech.com.cnCorporate Office
- Number 288, Jiangyun Road
- Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
Corporate Office
- Number 288, Jiangyun Road
- Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
Crystal Pharmatech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 02-Oct-2021 | $92.8M | Cancelled | Profitable | ||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Profitable | |||
| 5. Secondary Transaction - Private | 09-Mar-2020 | Completed | Profitable | |||
| 4. Secondary Transaction - Private | 31-Oct-2019 | Completed | Profitable | |||
| 3. Later Stage VC (Series B) | 07-Nov-2018 | Completed | Profitable | |||
| 2. Later Stage VC | 18-Sep-2017 | $5.38M | $15.4M | Completed | Profitable | |
| 1. Later Stage VC (Series A) | 16-Sep-2015 | $10M | $10M | Completed | Generating Revenue |
Crystal Pharmatech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Crystal Pharmatech Comparisons
Industry
Financing
Details
Crystal Pharmatech Competitors (34)
One of Crystal Pharmatech’s 34 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| TCG Lifesciences | Corporation | Kolkata, India | ||||
| Caidya | Private Equity-Backed | Raleigh, NC | ||||
| Accell Clinical Research | Corporation | Warrenton, VA | ||||
| KBI BioPharma | Formerly VC-backed | Durham, NC |
Crystal Pharmatech Patents
Crystal Pharmatech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026208703-A1 | Crystal form of vidofludimus calcium, preparation method therefor, and use thereof | Pending | 03-Apr-2025 | ||
| WO-2025167588-A1 | Crystal form of zipalertinib, and preparation method therefor and use thereof | Pending | 05-Feb-2024 | ||
| WO-2025140479-A1 | Crystal form of iclepertin, preparation method therefor, and use thereof | Inactive | 29-Dec-2023 | ||
| WO-2025107861-A1 | Crystal form of zasocitinib, preparation method therefor and use thereof | Inactive | 24-Nov-2023 | ||
| WO-2025026050-A1 | Crystal form of bezuclastinib, preparation method therefor and use thereof | Inactive | 28-Jul-2023 | C07D471/04 |
Crystal Pharmatech Signals
Crystal Pharmatech Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Suzhou Junshang Investment Management | Growth/Expansion | Minority | ||
| Tsinghua Holdings Capital | Growth/Expansion | Minority | ||
| Cowin Capital | Venture Capital | Minority | ||
| Shiyu Capital | Venture Capital | Minority |
Crystal Pharmatech Investments (4)
Crystal Pharmatech’s most recent deal was a Seed Round with Giiant Pharma for . The deal was made on 30-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Giiant Pharma | 30-Jun-2021 | Seed Round | Drug Discovery | ||
| Chiral Quest | 01-Feb-2021 | Corporate | Other Pharmaceuticals and Biotechnology | ||
| Laviana | 18-Apr-2018 | Later Stage VC | Clinics/Outpatient Services | ||
| F&S Pharmatech | 21-Oct-2015 | Corporate | Other Pharmaceuticals and Biotechnology |
Crystal Pharmatech FAQs
-
When was Crystal Pharmatech founded?
Crystal Pharmatech was founded in 2010.
-
Where is Crystal Pharmatech headquartered?
Crystal Pharmatech is headquartered in Suzhou, China.
-
What is the size of Crystal Pharmatech?
Crystal Pharmatech has 180 total employees.
-
What industry is Crystal Pharmatech in?
Crystal Pharmatech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Crystal Pharmatech a private or public company?
Crystal Pharmatech is a Private company.
-
What is the current valuation of Crystal Pharmatech?
The current valuation of Crystal Pharmatech is .
-
What is Crystal Pharmatech’s current revenue?
The current revenue for Crystal Pharmatech is .
-
How much funding has Crystal Pharmatech raised over time?
Crystal Pharmatech has raised $37M.
-
Who are Crystal Pharmatech’s investors?
CONNECT (San Diego), Suzhou Junshang Investment Management, Tsinghua Holdings Capital, Cowin Capital, and Shiyu Capital are 5 of 7 investors who have invested in Crystal Pharmatech.
-
Who are Crystal Pharmatech’s competitors?
Charles River Laboratories International, TCG Lifesciences, Caidya, Accell Clinical Research, and KBI BioPharma are some of the 34 competitors of Crystal Pharmatech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process